Home About Us Investigators Research Focus Publications Graduate/Academic    
 
 
 
 
ALL   |   ABC  |   DEF  |   GHI  |   JKL  |   MNO  |   PQRS  |   TUV  |   WXYZ

Patrick Boon Ooi TAN, M.D. Ph.D.
Group Leader
tanbop@gis.a-star.edu.sg
RESEARCH FOCUS

Our research group utilizes a variety of genomic technologies including DNA microarrays, high-throughput sequencing, and bioinformatics to understand the genetic and molecular basis of host-pathogen interactions. Our disease focus is tropical infectious disease, as there are a number of tropical pathogens which cause serious disease in the region but for which little is known about their mechanism of virulence. We have been investigating the Gram negative saprophyte Burkholderia pseudomallei, the causative agent of meliodosis, an often fatal disease of humans and animals. The B. pseudomallei genome, at 7.2 Mb, is also one of the most complex microbial genomes sequenced to date.

We have found that B. pseudomallei is pathogenic to C. elegans, and that the mechanism of virulence is most likely conserved between nematodes and higher vertebrates. Using this assay, we have identified a number of novel virulence factors in the pathogen, and we are currently investigating if certain genetic or environmental factors can predispose a host towards an infection. We are also using whole-genome B. pseudomallei microarrays to study patterns of genomic variation in the natural environment.

We have also engaged in an intensive research program on cancer of the stomach, associated with the Duke-NUS Graduate Medical School (www.duke-nus.edu.sg)


 
 
EDUCATION

1992-2000    Stanford University School of Medicine, MD PhD
1988-1992    Harvard University, B.A.
1986-1987    National Junior College, Singapore


PROFESSIONAL APPOINTMENTS

2004 - Present    Group Leader, Genome Institute of Singapore
2006- Present    Associate Professor, Duke-NUS Graduate Medical School Singapore
2009 – Present    Director, Duke-NUS Genome Biology Facility
2009 – Present    Research Associate Professor, Institute of Genome Sciences and Policy, Duke University
2008 - Present    Program Leader, Genomic Oncology, Cancer Science Institute of Singapore (NUS)
2006 - Present    Principal Investigator (Adjunct), National Cancer Centre, Singapore
2003 - Present    Associate Professor (Adjunct), Dept of Physiology, National University of Singapore
2004 - Present    Senior Research Fellow (Adjunct), Defence Medical and Environmental Research Institute, Defence Science Organization (DMERI@DSO), Singapore
2005 - 2008    Associate Professor (Adjunct), School of Computer Science, Nanyang Technological University, Singapore
2002 – 2007    Chief Scientific Officer, Agenica Research Pte Ltd (Joint Venture with NCCS, Mitsui Corp, and Shimadzu Corp)
2002 - 2006    Principal Investigator, National Cancer Centre, Singapore
2003 - 2004    Senior Research Fellow, Defence Medical and Environmental Research Institute (DMERI@DSO), Singapore
2004    Visiting Scientist, Broad Institute, Cambridge, MA
2000 - 2003    Research Scientist, Defence Medical Research Institute, Singapore
2000 - 2002    Senior Scientist, National Cancer Centre, Singapore


HONORS AND AWARDS

1987     President's Scholarship, Singapore
1992     Graduated summa cum laude (Highest Honors), Harvard University
1992     Phi Beta Kappa Society
1992     Fairchild Fellowship (for MSTP training), Stanford University
1998     Charles Yanofsky Award for Most Outstanding Graduate Thesis, Stanford University
2001     Young Scientist Award (Singapore National Academy of Sciences)
2001     NCC Academic Award for Best Intellectual Property Filing
2002     NCC Academic Award for Best New Research Programme
2002     Singapore Youth Award (National Youth Council)
2002     Best Business Plan and Executive Summary (Systome Therapeutics), Startup@Singapore National Techno-Venture Competition
2004     Singhealth Investigator Excellence Award
2005     AACR-ITO EN Scholar in Training Award, AACR 96th Annual Meeting
2008     Singapore Youth Award, Medal of Commendation (National Youth Council)
2010     AACR-Bristol-Myers Squibb Oncology Scholar-in-Training Award (for graduate student Iain Tan)
2010     ASCO Young Investigator Award (for graduate student Iain Tan)
1987     1987 Loke Cheng Kim Scholarship, Singapore
1988     1988 Detur Prize for Academic Excellence, Harvard University
1991     Signet Society, Harvard University


COMMITTEE AND ADVISORY BOARD

2003    Member, Pro-term Committee, Duke-NUS Graduate Medical School
2003    Chair, Technology Scan Panel on Engineering Science in Medicine, Agency for Science, Technology and Research
2004    Chair, Scientific Committee, 4th World Melioidosis Congress
2005-2007    Chair, Life Sciences Virtual Grid Community, National Grid Office
2005    Working Committee, Molecular Pathology of Breast Cancer, International Agency for Research on Cancer (IARC), Lyon, France
2006    Member, International Advisory Committee, 5th World Melioidosis Congress
2007    Program Committee, AACR Centennial Conference
2007    Course Co-director, Molecules and Cells, Duke-NUS Graduate Medical School (Inaugural Class)
2008    Member, International Scientific Committee, International Society for Cellular Oncology
2009 – Present    Member, Scientific Advisory Board, Eskitis Institute for Cell and Molecular Therapies, Griffith University, Australia
2004 - Present    Member, Local Review Panel, Translational Research, Biomedical Research Council
2007 - Present    Member, Bioethics Advisory Committee (National Committee)
2007 - Present    Member, Local Review Panel, National Medical Research Council, Singapore
2007 - Present    Member, Specialists Accreditation Board, Translational Medicine
2008 – Present    Faculty Member, Singapore – MIT Computational and Systems Biology (CSB) Programme, NUS
2003 - 2004    Editorial Board Member, Cancer Reviews : Asia Pacific (World Scientific Press)
2007 – Present    Associate Editor, BMC Medical Genomics (Biomed Central)
2009- Present    Editorial Board Member, PLoS One
2007    Organizing Committee, AACR Centennial Conference on Translational Cancer Research, Singapore
2009    Session Chair, New Concepts in Organ Site Research (Gastric Cancer), 2010 American Association for Cancer Research Annual Meeting, Washington DC
2009    Member, International Scientific Committee, International Society for Cellular Oncology Meeting, Dresden, Germany
2010    Member, Gastric Cancer Advisory Committee, Bristol-Myers Squibb
2004 - 2009    Editorial Board Member, SGH Proceedings, Singapore
2005 - 2009    Associate Editor, Cancer Research (American Association for Cancer Research)
2008    Program Committee, AACR Centennial Conference, Singapore
2010    Member, Clinical Advisory Board, Siena Biotech
2010 - present    Editoial Board Member, Cellular Oncology


EXTERNAL GRANT

Sep 2009 - Sep 2010 Subaward from NUS as part of a research collaboration by Bayer Schering Pharma (S$200,000)
Oct 2007 - Sep 2012 TCR Flagship Programme “The Singapore gastric cancer consortium-improving outcomes for our patients”, PI (NCC Module) by National Medical Research Council ($4,997,500)
Oct 2005 – Sep 2008 Systematic Identification of Candidate Cancer and Biomarker Genes by High Resolution Mapping of Genomic Aberrations Using a Microarray Platform by Singapore Cancer Syndicate, A-STAR ($850,062)
Oct 2005 – Mar 2008 A Personalised and Adaptive Lliterature Curation System for the Biomedical Sciences by National Grid Office ($280,400)
July 2003 – June 2007 Regulation and Function of Lin-31, a gene important in RAS/MAPK signaling specificity during C. elegans vulval induction by Biomedical Research Council ($800,000)
Feb 2006 - Jan 2011 Systematic Identification of Oncogenic Cellular Pathways and Processes in Gastric Cancer for patient stratification and personalized therapy by Biomedical Research Council, A-star ($1,890,000)
Apr 2006 - Mar 2009 Establishment of the National Xenograft Therapeutic Program by Singapore Cancer Syndicate, A-star ($920,000)
Apr 2006 - Mar 2008 Functional characterization of PLA2G2A in gastric cancer by Singhealth ($200,000)
Apr 2006 - Jun 2010 Establishment of the National Xenograft Therapeutic Program by Singapore Cancer Syndicate, A-star ($920,000)
Apr 2003 – Mar 2006 Identification of Novel Cancer Subtypes and Genetic Identifiers Using Genome-Level Targeted Technologies by , Biomedical Research Council ($1,550,800)


PATENTS

2008 EP1668151B1 :   Materials and Methods Related to Breast Cancer Dia   (Granted)
2008 160726 :   Materials and Methods Related to Breast Cancer Dia   (Granted)
2006 200404696-7 :   Materials and Methods for Cancer Diagnosis   (Granted)


SELECTED PUBLICATIONS

1.   Nandi T, Ong C, Singh AP, Boddey J, Atkins T, Sarkar-Tyson M, Essex-Lopresti AE, Chua HH, Pearson T, Kreisberg JF, Nilsson C, Ariyaratne P, Ronning C, Losada L, Ruan Y, Sung WK, Woods D, Titball RW, Beacham I, Peak I, Keim P, Nierman WC, Tan P "A genomic survey of positive selection in Burkholderia pseudomallei provides insights into the evolution of accidental virulence." PLoS Pathog 2010 ; 6(4) : e1000845 Epub 2010 Apr 1
Abstract    
2.   Bernice Meng Qi Sim, Narisara Chantratita, Vanaporn Wuthiekanun, Janjira Thaipadungpanit, Sarinna Tumupa, Chi Ho Lin, Tannistha Nandi, Hui Hoon Chua, Yichun Liu, Edward J. Feil, Mindy Glass, Gladys Tan, Sharon J. Peacock, Patrick Tan (2010) Genomic Acquisition of Virulence Factors by Natural Isolates of Burkholderia. Genome Biology 11:R89
3.   Chi Ho Lin, Guillaume Bourque, and Patrick Tan (2008) A Comparative Synteny Map of Burkholderia Species Links Large-scale Genome Rearrangements to Fine-scale Nucleotide Variation in Prokaryotes. Molecular Biology and Evolution, 25(3):549-558
4.   Sharon J. Peacock, Herbert P. Schweizer, David A.B. Dance, Theresa L. Smith, Jay E. Gee, Vanaporn Wuthiekanun, David DeShazer, Ivo Steinmetz, Patrick Tan and Bart J. Currie (2008) Consensus guidelines on the management of accidental laboratory exposure to Burkholderia pseudomallei and Burkholderia mallei. Emerging Infectious Diseases. Available from http://www.cdc.gov/EID/content/14/7/07-1501.htm DOI: 10.3201/eid1407.071501
5.   Siew Hoon Sim, Yiting Yu, Chi Ho Lin, R. Krishna M. Karuturi, Vanaporn Wuthiekanun, Apichai Tuanyok, Hui Hoon Chua, Catherine Ong, Sivalingam Suppiah Paramalingam, Gladys Tan, Lynn Tang, Gary Lau, Eng Eong Ooi, Donald Woods, Edward Feil, Sharon J. Peacock, and Patrick Tan (2008) The Core and Accessory Genomes of Burkholderia pseudomallei: Implications for Human Melioidosis. PLoS Pathogens. 4(10): e1000178.
6.   Yu Y, Kim HS, Chua HH, Lin CH, Sim SH, Lin D, Derr A, Engels R, DeShazer D, Birren B, Nierman WC, Tan P. (2006) Genomic patterns of pathogen evolution revealed by comparison of Burkholderia pseudomallei, the causative agent of melioidosis, to avirulent Burkholderia thailandensis. BMC Microbiology 6, 46 (Designated a “Highly Accessed” Article)
7.   Fiona Rodrigues, Mitali Sarkar-Tyson, Sarah V Harding, Siew Hoon Sim, Hui Hoon Chua, Chi Ho Lin, Xu Han, R Krishna M Karuturi, Ken Sung, Kun Yu, Wei Chen, Timothy P Atkins, Richard W Titball, and Patrick Tan (2006) A Global Map of Growth Regulated Gene Expression in Burkholderia pseudomallei, the Causative Agent of Melioidosis, J. Bacteriology 188, 8178-8188 (COVER IMAGE)
Supplemental Data File    
8.   Keli Ou, Catherine Ong, Shze Yung Koh, Fiona Rodrigues, Siew Hoon Sim, Daniel Wong, Chia Huey Ooi, Kim Chong Ng, Hiroyuki Jikuya, Chin Chin Yau, Sou Yen Soon, Djohan Kesuma, May Ann Lee, and Patrick Tan (2005) Integrative Genomic, Transcriptional, and Proteomic Diversity in Natural Isolates of the Human Pathogen Burkholderia pseudomallei, J. Bacteriology 187, 4276-4285 (Impact factor: 3.993)
9.   Catherine Ong, Ooi Chia Huey, Dongling Wang, Hweeling Chong, Ng Kim Chong, Fiona Rodrigues, May Ann Lee, and Patrick Tan (2004) Patterns of Large-Scale Genomic Variation in Virulent and Avirulent Burkholderia Species, Genome Research 14, 2295-2307
10.   Gan, YH, Chua, KL, Chua, HH, Chong, HL, and Tan, P (2002) Identification of Novel Virulence Factors In Burkholderia Pseudomallei Using a C. Elegans Pathogenesis Model. Molecular Microbiology 44(5), 1185-1197

COMPLETE PUBLICATION LIST

 Please Click Here